Ke Yuan

1.3k total citations · 1 hit paper
45 papers, 790 citations indexed

About

Ke Yuan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ke Yuan has authored 45 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Ke Yuan's work include Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and MicroRNA in disease regulation (5 papers). Ke Yuan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers) and MicroRNA in disease regulation (5 papers). Ke Yuan collaborates with scholars based in United States, China and Japan. Ke Yuan's co-authors include Vinicio A. de Jesús Pérez, Mark Orcholski, Mark R. Nicolls, Wen Tian, Elya A. Shamskhou, Abinaya Nathan, Lingli Wang, Xinguo Jiang, Benjamin A. Raby and Hyunbum Kim and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ke Yuan

38 papers receiving 788 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition

2025 17 citations Ke Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ke Yuan United States	16	373	248	121	93	90	45	790
Robert Szulcek Netherlands	17	372 1.0×	389 1.6×	207 1.7×	130 1.4×	98 1.1×	34	1.0k
Óscar Busnadiego Spain	12	195 0.5×	309 1.2×	156 1.3×	102 1.1×	74 0.8×	12	761
Wenmei Zhang China	15	191 0.5×	254 1.0×	86 0.7×	103 1.1×	145 1.6×	35	615
Patricia Zadigue France	12	558 1.5×	252 1.0×	271 2.2×	63 0.7×	56 0.6×	16	815
Jiumei Cao China	16	401 1.1×	206 0.8×	160 1.3×	100 1.1×	46 0.5×	26	860
Evelina Fagone Italy	16	606 1.6×	251 1.0×	42 0.3×	51 0.5×	85 0.9×	25	973
Stephen Seedial United States	13	193 0.5×	218 0.9×	60 0.5×	86 0.9×	52 0.6×	18	688
Derek Lee United States	15	225 0.6×	423 1.7×	58 0.5×	135 1.5×	105 1.2×	33	904
Mhairi J. Maxwell Australia	17	255 0.7×	237 1.0×	145 1.2×	43 0.5×	341 3.8×	26	1.0k

Countries citing papers authored by Ke Yuan

Since Specialization

Citations

This map shows the geographic impact of Ke Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Yuan more than expected).

Fields of papers citing papers by Ke Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Yuan. The network helps show where Ke Yuan may publish in the future.

Co-authorship network of co-authors of Ke Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Yuan. A scholar is included among the top collaborators of Ke Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Yuan. Ke Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Ke, et al.. (2025). Efficacy of wound care ointment in healing infectious wounds after anorectal surgery: A randomized controlled trial. Medicine. 104(4). e41347–e41347.

Yuan, Ke, Barbara R. Evans, Juliane Weber, et al.. (2025). Acidities of MgO surface sites: implications for the formation mechanism of Mg(OH) ₂. Journal of Materials Chemistry A. 13(33). 27367–27376.

Baek, Seung Han, Yan Li, Yu Liu, et al.. (2025). Specialized pericyte subtypes in the pulmonary capillaries. The EMBO Journal. 44(4). 1074–1106. 4 indexed citations

Tsikis, Savas T., Yan Li, Zhiyue Zhao, et al.. (2025). Smooth muscle Cxcl12 contributions to vascular remodeling in flow and hypoxia-induced pulmonary hypertension. Journal of Biological Chemistry. 301(6). 110207–110207.

Du, Xuewei, Fangjun Shu, Huiyao Wang, et al.. (2024). Mechanisms of electromagnetic field control on mineral scaling in brackish water reverse osmosis: Combined homogenous and heterogeneous nucleation. Separation and Purification Technology. 355. 129630–129630. 6 indexed citations

Du, Xuewei, Wenbin Jiang, Fangjun Shu, et al.. (2024). Numerical modeling of electromagnetic field spatiotemporal evolution to evaluate the effects on calcium carbonate crystallization. Desalination. 592. 118128–118128. 4 indexed citations

Tabib, Tracy, Mengqi Huang, Ke Yuan, et al.. (2024). Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis–Associated and Idiopathic Pulmonary Hypertension. Arteriosclerosis Thrombosis and Vascular Biology. 44(8). e210–e225. 6 indexed citations

Feng, Yu, Ke Yuan, Zitong Yu, et al.. (2024). scMMAE: masked cross-attention network for single-cell multimodal omics fusion to enhance unimodal omics. Briefings in Bioinformatics. 26(1).

Kwiatkowski, Nicholas, Sha Zhou, Paul Collier, et al.. (2024). 104 (PB092): CDK2 heterobifunctional degraders co-degrade CDK2 and Cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers. European Journal of Cancer. 211. 114627–114627.

10.

Dong, Yunzhou, Beibei Wang, Mulong Du, et al.. (2023). Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis. Circulation. 147(8). 669–685. 33 indexed citations

11.

Chen, Xi, et al.. (2023). The toxicokinetic and extracorporeal removal of bongkrekic acid during blood purification therapies: A case report. Toxicon. 233. 107275–107275. 7 indexed citations

12.

Tsikis, Savas T., Scott C. Fligor, Tiffany Liu, et al.. (2023). A pneumonectomy model to study flow-induced pulmonary hypertension and compensatory lung growth. Cell Reports Methods. 3(10). 100613–100613. 6 indexed citations

13.

Taglauer, Elizabeth S., Elisha M. Wachman, Lillian J. Juttukonda, et al.. (2022). Acute Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy Is Associated with Placental Angiotensin-Converting Enzyme 2 Shedding. American Journal Of Pathology. 192(4). 595–603. 11 indexed citations

14.

Mesentier‐Louro, Louise A., Laurel Stell, Mohammad Ali Shariati, et al.. (2021). Hypoxia-induced inflammation: Profiling the first 24-hour posthypoxic plasma and central nervous system changes. PLoS ONE. 16(3). e0246681–e0246681. 13 indexed citations

15.

Yuan, Ke, et al.. (2021). Inflammation in Pulmonary Arterial Hypertension. Advances in experimental medicine and biology. 1303. 351–372. 24 indexed citations

16.

Yuan, Ke, Yu Liu, Yue Zhang, et al.. (2020). Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 62(6). 747–759. 34 indexed citations

17.

Kelleher, Joseph F., Veronica A. Campbell, Jared Gollob, et al.. (2019). KYM‐001, A FIRST‐IN‐CLASS ORAL IRAK4 PROTEIN DEGRADER, INDUCES TUMOR REGRESSION IN XENOGRAFT MODELS OF MYD88‐MUTANT ABC DLBCL ALONE AND IN COMBINATION WITH BTK INHIBITION. Hematological Oncology. 37(S2). 129–129. 4 indexed citations

18.

Wang, Yan, Rongjie Lin, Ke Yuan, et al.. (2019). Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer. Signal Transduction and Targeted Therapy. 4(1). 52–52. 5 indexed citations

19.

Yuan, Ke, Ning‐Yi Shao, Jan K. Hennigs, et al.. (2016). Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension. American Journal Of Pathology. 186(9). 2500–2514. 43 indexed citations

20.

Yuan, Ke, Mark Orcholski, Cristina Panaroni, et al.. (2014). Activation of the Wnt/Planar Cell Polarity Pathway Is Required for Pericyte Recruitment during Pulmonary Angiogenesis. American Journal Of Pathology. 185(1). 69–84. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact